Epirubicin responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of: breast cancer; gastric cancer; ovarian cancer; small cell lung cancer; lymphoma (non-Hodgkin’s lymphoma); advanced/metastatic soft tissue sarcoma; superficial bladder cancer.
- Mon - Fri 09:00 - 19:00
- (+84)28 225 35 475
